News

The new firm, TandemAI will offer partners an expanded range of methods and workflows for small-molecule and peptide drug ...
In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across ...
The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX Ventures, bringing its total ...
Through the alliance, Hippocratic AI's generative AI healthcare agents will be constructed for "patient-facing non-diagnostic ...
The company will use the funds to move into the female health space and increase screening and preventive care.
In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.
Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...
Unveiled at Galaxy Unpacked, the new lineup includes sleep apnea detection, vascular stress monitoring and the first ...
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.